Hadean Ventures
Overview
Hadean Ventures is a European life science venture capital firm based in Oslo, Norway, investing across healthcare and life science sectors to address unmet medical needs.
Classification
- Headquarters
- Helsinki, Finland
- Geographic focus
- Europe, with a Nordic emphasis
- Stage
- any
- Current fund
- Hadean Capital II
- Fund status
- active
- Portfolio
- 1 companies
Fund details
- Fund size
- EUR 230m AUM
- AUM
- c. EUR 230m
- Check size
- €3.7 M-€38 M
- Founded
- 2014
Thesis & focus
hands-on operational management of start-ups
Emergence Therapeutics – acquired by Eli Lilly (2023)
European life science, all healthcare verticals and stages
Team combines in-depth knowledge of medicine and life science, extensive investment experience at prestigious venture capital funds, and a strong track record of hands-on operational management of start-ups.
Investment thesis
Invests across all healthcare verticals and stages in products with the potential to address unmet medical needs. The firm aims to make a difference by investing in the future of healthcare.
Partners 2
Portfolio companies
No portfolio companies linked yet.
Co-investors
Loading co-investment network…
No co-invest data available.
Source: vc_export
Website preview visit ↗
